BlackRock Institutional Trust’s Harvard Bioscience HBIO Stock Holding History

BlackRock Institutional Trust’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.54M	Buy	116,106 +1,537	+1%	+$39.1K	﹤0.01%	2849
2016 Q3	$3.12M	Buy	114,569 +3,833	+3%	+$106K	﹤0.01%	2881
2016 Q2	$3.17M	Sell	110,736 -31,159	-22%	-$991K	﹤0.01%	2864
2016 Q1	$4.29M	Sell	141,895 -1,183	-0.8%	-$33.5K	﹤0.01%	2743
2015 Q4	$4.96M	Buy	143,078 +11,813	+9%	+$404K	﹤0.01%	2732
2015 Q3	$4.96M	Sell	131,265 -13,187	-9%	-$614K	﹤0.01%	2725
2015 Q2	$8.23M	Buy	144,452 +10,793	+8%	+$614K	﹤0.01%	2523
2015 Q1	$7.78M	Sell	133,659 -4,180	-3%	-$225K	﹤0.01%	2546
2014 Q4	$7.82M	Buy	137,839 +8,455	+7%	+$403K	﹤0.01%	2508
2014 Q3	$5.29M	Buy	129,384 +6,727	+5%	+$309K	﹤0.01%	2664
2014 Q2	$5.58M	Sell	122,657 -51,374	-30%	-$2.16M	﹤0.01%	2737
2014 Q1	$8.25M	Buy	174,031 +14,648	+9%	+$667K	﹤0.01%	2540
2013 Q4	$7.49M	Sell	159,383 -69,575	-30%	-$3.04M	﹤0.01%	2586
2013 Q3	$9.13M	Sell	228,958 -61,617	-21%	-$2.42M	﹤0.01%	2419
2013 Q2	$10.4M	Buy	+290,575	New	+$11.1M	﹤0.01%	2295

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPC

Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Foundry Partners Minneapolis, Minnesota $1.89B AUM 9.84% 1-Year Est. Return

BlackRock Institutional Trust's HBIO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Harvard Bioscience (HBIO) stake by 1.3% in Q4 2016, buying an estimated $39.1K and bringing the position to 116,106 shares worth $3.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2849.

BlackRock Institutional Trust first reported a position in HBIO in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.4M in Q2 2013. 68 funds tracked by Wall St. Rank hold HBIO as of Q4 2016.

BlackRock Institutional Trust held 116,106 shares of Harvard Bioscience worth $3.54M as of Q4 2016.
BlackRock Institutional Trust bought 1,537 Harvard Bioscience shares in Q4 2016, an estimated $39.1K.
Harvard Bioscience made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2849 holding.
BlackRock Institutional Trust first reported a position in Harvard Bioscience in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Harvard Bioscience position peaked at $10.4M in Q2 2013.
68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.